1. Home
  2. Search by Resource
  3. Public Health Announcements
  4. Search for Resource

Library & Search Results

Doxycycline Postexposure Prophylaxis to Prevent Bacterial Sexually Transmitted Infection

Author/s: John Flores, Andrew M Davis, Aniruddha Hazra

This JAMA Guidelines Synopsis summarizes the 2024 Centers for Disease Control and Prevention guidelines on use of doxycycline postexposure prophylaxis (doxyPEP) for bacterial sexually transmitted infection prevention.
Keywords/Tags:
sexually transmitted diseases doxycycline

2025 Immunization Schedules approved by ACIP

The 2025 Immunization Schedules approved by ACIP and adopted by the CDC Director on October 24, 2024 are now available below.
Keywords/Tags:
Immunization Immunization Schedule schedule vaccines

Recommended Immunizations for Children 7–18 Years Old, United States, 2024

This parent-friendly schedule is recommended by the Advisory Committee on Immunization Practices (ACIP) and approved by the Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics (AAP), and American Academy of Family Physicians (AAFP).
Keywords/Tags:
Immunization Immunization Schedule vaccination vaccination recommendations

Recommended Immunizations for Birth Through 6 Years Old, United States, 2024

This parent-friendly schedule is recommended by the Advisory Committee on Immunization Practices (ACIP) and approved by the Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics (AAP), and American Academy of Family Physicians (AAFP).
Keywords/Tags:
Immunization Schedule Immunization vaccination vaccination recommendations

Immunization Schedules

Child, adolescent, and adult immunization schedules from the CDC for 2024.
Keywords/Tags:
Immunization Schedule adult immunization Immunization children's health adolescents children Adults

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season

Author/s: Grohskopf, L. A., Alyanak, E., Ferdinands, J. M., Broder, K. R., Blanton, L. H., Talbot, H. K., Fry, A. M.

This report updates the 2020–21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]). Routine annual influenza vaccination is recommended for all persons aged ≥6 months...

Rickettsial Disease Diagnostic Testing and Interpretation

Author/s: Centers for Disease Control and Prevention

This video provides information on rickettsial disease diagnostic methods for healthcare providers, including what tests are available and when it is most appropriate to collect samples. This video focuses on the use of polymerase chain reaction (or PCR) tests, and the indirect...

Keywords/Tags:
Rickettsial diagnostic healthcare tests PCR

Child & Adolescent Immunization Schedule

Author/s: Advisory Committee on Immunization Practices

COVID-19 Vaccination

ACIP recommends use of COVID-19 vaccines within the scope of the Emergency Use Authorization or Biologics License Application for the particular vaccine.  Interim ACIP recommendations for the use of COVID-19 vaccines can be found on the ...

Keywords/Tags:
COVID-19 COVID-19 vaccine Pfizer–BioNTech mRNA vaccine child adolescent

Foodborne illness source attribution estimates for 2018 for Salmonella, Escherichia coli O157, Listeria monocytogenes, and Campylobacter using multi-year outbreak surveillance data, United States

Each year in the United States an estimated 9 million people get sick, 56,000 are hospitalized, and 1,300 die of foodborne disease caused by known pathogens. These estimates help us understand the scope of this public health problem. However, to develop effective prevention measures, we need to...

Keywords/Tags:
Foodborne Diseases Food Safety Salmonella Centers for Disease Control and Prevention CDC public health

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

Author/s: Oliver, Sara E., Gargano, Julia W., Marin, Mona, Wallace, Megan, Curran, Kathryn G., Chamberland, Mary, McClung, Nancy, Campos-Outcalt, Doug, Morgan, Rebecca L., Mbaeyi, Sarah, Romero, Jose R., Talbot, H.K., Lee, Grace M., Bell, Beth P., Dooling, Kathleen

On December 11, 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine (Pfizer, Inc; Philadelphia, Pennsylvania), a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike...

Keywords/Tags:
immunizations Pfizer–BioNTech mRNA vaccine Pfizer COVID-19 COVID-19 vaccine coronavirus SARS coronavirus SARS-CoV-2

RPR User Guide

Research-to-Practice-to-Research (RPR) Exchange

If you need assistance with the RPR Exchange, please use the QOS form and leave a question or suggestion.  We review them regularly and will get back with you.  If you  need general information about using the RPR Exchange, the User Guide is available on-line.  You might also find the FAQs useful for some of the common questions RPR users have.